{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:51:38Z","timestamp":1791888698443,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.clineuro.2024.108191","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T11:30:45Z","timestamp":1708774245000},"page":"108191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Brain metastases from renal cell carcinoma: Effects of novel systemic agents on brain metastasis outcomes"],"prefix":"10.1016","volume":"238","author":[{"given":"Hadley W.","family":"Ressler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina K.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Isom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7242-3315","authenticated-orcid":false,"given":"Jimmy","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6350-0764","authenticated-orcid":false,"given":"Fei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Whitlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian W.","family":"Laxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Tatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clineuro.2024.108191_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108191_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11060-022-03951-7","article-title":"Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases","volume":"157","author":"Abdulhaleem","year":"2022","journal-title":"J. Neurooncol."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108191_bib3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/neuros\/nyy216","article-title":"Does stereotactic radiosurgery have a role in the management of patients presenting with 4 or more brain metastases?","volume":"84","author":"Soike","year":"2019","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.clineuro.2024.108191_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0360-3016(97)00006-0","article-title":"External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center","volume":"37","author":"Wr\u00f3nski","year":"1997","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108191_bib5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3171\/2012.2.JNS111353","article-title":"The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery","volume":"116","author":"Cochran","year":"2012","journal-title":"J. Neurosurg."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108191_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N. Engl. J. Med"},{"issue":"22","key":"10.1016\/j.clineuro.2024.108191_bib7","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.clineuro.2024.108191_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","volume":"349","author":"Yang","year":"2003","journal-title":"N. Engl. J. Med"},{"issue":"22","key":"10.1016\/j.clineuro.2024.108191_bib9","doi-asserted-by":"crossref","first-page":"18945","DOI":"10.18632\/oncotarget.4153","article-title":"Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases","volume":"6","author":"Johnson","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.clineuro.2024.108191_bib10","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini","year":"2019","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108191_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000891","volume":"8","author":"Motzer","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.clineuro.2024.108191_bib12","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/ijms21072532","article-title":"Immunotherapy in renal cell carcinoma: the future is now","volume":"21","author":"Deleuze","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108191_bib13","first-page":"402","article-title":"Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries","volume":"6","author":"Lanier","year":"2019","journal-title":"Neurooncol. Pract."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108191_bib14","first-page":"77","article-title":"Upfront immunotherapy leads to lower brain metastasis velocity in patients undergoing stereotactic radiosurgery for brain metastases","volume":"8","author":"Abdulhaleem","year":"2022","journal-title":"J. Radio. SBRT"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108191_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijrobp.2020.06.057","article-title":"Predictors of adverse radiation effect in brain metastasis patients treated with stereotactic radiosurgery and immune checkpoint inhibitor therapy","volume":"108","author":"Helis","year":"2020","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108191_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.clineuro.2024.108191_bib17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/neuonc\/nou018","article-title":"A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy","volume":"16","author":"Ayala-Peacock","year":"2014","journal-title":"Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108191_bib18","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.ijrobp.2011.11.059","article-title":"Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer","volume":"83","author":"Harris","year":"2012","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108191_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijrobp.2017.01.201","article-title":"Brain metastasis velocity: a novel prognostic metric predictive of overall survival and freedom from whole-brain radiation therapy after distant brain failure following upfront radiosurgery alone","volume":"98","author":"Farris","year":"2017","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108191_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/annonc\/mdx740","article-title":"Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis","volume":"29","author":"McTyre","year":"2018","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108191_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of Radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724000787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724000787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:45:00Z","timestamp":1759589100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846724000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":21,"alternative-id":["S0303846724000787"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108191","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain metastases from renal cell carcinoma: Effects of novel systemic agents on brain metastasis outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108191"}}